Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Geriatric Psychiatry | 13 | 2021 | 70 | 3.550 |
Why?
|
Electroconvulsive Therapy | 15 | 2023 | 477 | 3.040 |
Why?
|
Dementia | 22 | 2023 | 2518 | 2.930 |
Why?
|
Bipolar Disorder | 34 | 2024 | 5027 | 2.870 |
Why?
|
Psychomotor Agitation | 14 | 2023 | 293 | 2.250 |
Why?
|
Alzheimer Disease | 19 | 2023 | 8037 | 1.510 |
Why?
|
Antipsychotic Agents | 10 | 2022 | 3057 | 1.460 |
Why?
|
Antimanic Agents | 4 | 2018 | 522 | 1.430 |
Why?
|
Depressive Disorder, Major | 20 | 2024 | 4644 | 1.330 |
Why?
|
Aging | 23 | 2024 | 8664 | 1.250 |
Why?
|
Spirituality | 5 | 2022 | 405 | 1.240 |
Why?
|
Antidepressive Agents | 9 | 2020 | 2838 | 1.050 |
Why?
|
Mental Disorders | 12 | 2021 | 6600 | 0.970 |
Why?
|
Aggression | 8 | 2022 | 753 | 0.970 |
Why?
|
Mood Disorders | 2 | 2022 | 1106 | 0.900 |
Why?
|
Ubiquinone | 2 | 2015 | 188 | 0.840 |
Why?
|
Aspartic Acid | 2 | 2019 | 576 | 0.840 |
Why?
|
Religion | 4 | 2022 | 356 | 0.790 |
Why?
|
Magnetic Resonance Spectroscopy | 9 | 2021 | 3760 | 0.780 |
Why?
|
Coronavirus Infections | 6 | 2020 | 3133 | 0.780 |
Why?
|
Pneumonia, Viral | 6 | 2020 | 3240 | 0.770 |
Why?
|
Long-Term Care | 2 | 2020 | 607 | 0.770 |
Why?
|
Caregivers | 6 | 2023 | 2094 | 0.750 |
Why?
|
Energy Metabolism | 7 | 2021 | 2899 | 0.680 |
Why?
|
Lithium Compounds | 5 | 2022 | 225 | 0.660 |
Why?
|
Inpatients | 2 | 2021 | 2518 | 0.650 |
Why?
|
Pandemics | 6 | 2020 | 8388 | 0.640 |
Why?
|
Psychiatric Department, Hospital | 1 | 2018 | 135 | 0.630 |
Why?
|
Aged | 74 | 2024 | 163280 | 0.610 |
Why?
|
Depressive Disorder | 4 | 2021 | 3748 | 0.590 |
Why?
|
Organizational Innovation | 1 | 2020 | 559 | 0.590 |
Why?
|
Citalopram | 2 | 2020 | 403 | 0.580 |
Why?
|
Neuropsychological Tests | 9 | 2024 | 6993 | 0.580 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2021 | 6038 | 0.540 |
Why?
|
Phosphocreatine | 1 | 2016 | 269 | 0.520 |
Why?
|
Movement | 2 | 2019 | 1471 | 0.500 |
Why?
|
Valproic Acid | 3 | 2017 | 445 | 0.490 |
Why?
|
Humans | 134 | 2024 | 744343 | 0.480 |
Why?
|
Pharmacogenetics | 5 | 2020 | 675 | 0.470 |
Why?
|
Cognition Disorders | 3 | 2020 | 4043 | 0.450 |
Why?
|
Infection Control | 1 | 2020 | 966 | 0.440 |
Why?
|
Psychotic Disorders | 7 | 2021 | 3046 | 0.440 |
Why?
|
Health Services Needs and Demand | 2 | 2020 | 1411 | 0.440 |
Why?
|
Memory | 2 | 2020 | 2174 | 0.430 |
Why?
|
Geriatric Assessment | 5 | 2017 | 1372 | 0.430 |
Why?
|
Phosphates | 1 | 2016 | 786 | 0.420 |
Why?
|
Psychotropic Drugs | 6 | 2020 | 894 | 0.410 |
Why?
|
Assisted Living Facilities | 2 | 2014 | 25 | 0.410 |
Why?
|
Organophosphorus Compounds | 1 | 2013 | 215 | 0.410 |
Why?
|
Brain | 9 | 2021 | 26385 | 0.410 |
Why?
|
Hospice Care | 1 | 2018 | 672 | 0.400 |
Why?
|
Suicide | 1 | 2022 | 1477 | 0.400 |
Why?
|
Affective Symptoms | 1 | 2013 | 407 | 0.380 |
Why?
|
Primary Health Care | 5 | 2023 | 4558 | 0.380 |
Why?
|
Mental Health | 7 | 2023 | 3019 | 0.380 |
Why?
|
Sertraline | 2 | 2021 | 206 | 0.360 |
Why?
|
Creatine Kinase | 1 | 2012 | 694 | 0.360 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1504 | 0.350 |
Why?
|
Affect | 4 | 2023 | 1476 | 0.350 |
Why?
|
Curriculum | 3 | 2021 | 3605 | 0.350 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 2025 | 0.340 |
Why?
|
Lithium Carbonate | 2 | 2016 | 184 | 0.340 |
Why?
|
Home Care Services | 1 | 2015 | 606 | 0.330 |
Why?
|
Cognition | 15 | 2023 | 6770 | 0.330 |
Why?
|
Drug Utilization | 1 | 2015 | 1183 | 0.320 |
Why?
|
Patient Care Team | 1 | 2019 | 2531 | 0.310 |
Why?
|
Inositol | 1 | 2008 | 218 | 0.300 |
Why?
|
Health Services for the Aged | 2 | 2020 | 269 | 0.300 |
Why?
|
Religion and Psychology | 2 | 2022 | 171 | 0.300 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 7913 | 0.300 |
Why?
|
Executive Function | 1 | 2016 | 1364 | 0.290 |
Why?
|
Phospholipids | 1 | 2010 | 784 | 0.280 |
Why?
|
Depression | 5 | 2023 | 7766 | 0.280 |
Why?
|
Aged, 80 and over | 19 | 2019 | 57776 | 0.270 |
Why?
|
Male | 56 | 2024 | 350118 | 0.270 |
Why?
|
Health Care Costs | 1 | 2019 | 3209 | 0.270 |
Why?
|
Referral and Consultation | 1 | 2018 | 3528 | 0.270 |
Why?
|
Facial Expression | 2 | 2019 | 508 | 0.250 |
Why?
|
Brain Diseases | 1 | 2014 | 1563 | 0.250 |
Why?
|
Female | 55 | 2024 | 380194 | 0.250 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3158 | 0.250 |
Why?
|
Middle Aged | 42 | 2024 | 213383 | 0.240 |
Why?
|
Lithium | 3 | 2023 | 601 | 0.240 |
Why?
|
Treatment Failure | 2 | 2020 | 2618 | 0.240 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5708 | 0.230 |
Why?
|
Fellowships and Scholarships | 3 | 2021 | 1076 | 0.220 |
Why?
|
Education, Nursing | 1 | 2023 | 82 | 0.210 |
Why?
|
Mental Recall | 2 | 2020 | 1205 | 0.210 |
Why?
|
Financing, Organized | 1 | 2023 | 202 | 0.200 |
Why?
|
Psychotherapy | 3 | 2021 | 1643 | 0.200 |
Why?
|
Mental Health Services | 4 | 2021 | 1643 | 0.200 |
Why?
|
Health Services | 2 | 2023 | 758 | 0.190 |
Why?
|
Patient Preference | 2 | 2020 | 890 | 0.190 |
Why?
|
Radio Frequency Identification Device | 1 | 2020 | 21 | 0.180 |
Why?
|
Phosphorus Isotopes | 2 | 2010 | 126 | 0.180 |
Why?
|
Treatment Outcome | 18 | 2023 | 63114 | 0.180 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2020 | 115 | 0.180 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2020 | 106 | 0.180 |
Why?
|
Hospitalization | 2 | 2018 | 10262 | 0.170 |
Why?
|
Students, Medical | 3 | 2021 | 1862 | 0.170 |
Why?
|
Registries | 1 | 2015 | 8089 | 0.170 |
Why?
|
Remote Sensing Technology | 1 | 2020 | 90 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 9959 | 0.170 |
Why?
|
Cannabinoids | 1 | 2021 | 166 | 0.160 |
Why?
|
Civil Defense | 1 | 2020 | 109 | 0.160 |
Why?
|
Disease Progression | 2 | 2021 | 13284 | 0.160 |
Why?
|
Accreditation | 2 | 2021 | 450 | 0.160 |
Why?
|
Personnel Selection | 1 | 2020 | 189 | 0.160 |
Why?
|
Psychological Techniques | 1 | 2017 | 45 | 0.150 |
Why?
|
Expert Testimony | 1 | 2020 | 356 | 0.150 |
Why?
|
Drug Substitution | 1 | 2020 | 281 | 0.150 |
Why?
|
Narration | 1 | 2019 | 212 | 0.150 |
Why?
|
Case-Control Studies | 6 | 2020 | 21746 | 0.150 |
Why?
|
Emotions | 2 | 2019 | 2661 | 0.150 |
Why?
|
Creatine | 1 | 2019 | 421 | 0.140 |
Why?
|
Ketamine | 1 | 2022 | 500 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2017 | 6489 | 0.140 |
Why?
|
Glutamine | 1 | 2019 | 578 | 0.130 |
Why?
|
Age Factors | 7 | 2019 | 18370 | 0.130 |
Why?
|
Spectrum Analysis | 1 | 2017 | 454 | 0.130 |
Why?
|
Suicidal Ideation | 2 | 2022 | 1248 | 0.130 |
Why?
|
Memory Disorders | 2 | 2020 | 1184 | 0.130 |
Why?
|
Cross-Sectional Studies | 11 | 2022 | 25043 | 0.130 |
Why?
|
Placebos | 2 | 1999 | 1676 | 0.130 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5319 | 0.130 |
Why?
|
Spiritual Therapies | 1 | 2015 | 58 | 0.130 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2557 | 0.120 |
Why?
|
Disaster Medicine | 1 | 2015 | 75 | 0.120 |
Why?
|
Clinical Clerkship | 1 | 2020 | 532 | 0.120 |
Why?
|
Psychiatry | 2 | 2014 | 1695 | 0.120 |
Why?
|
Adult | 22 | 2024 | 214055 | 0.120 |
Why?
|
Activities of Daily Living | 5 | 2023 | 2418 | 0.120 |
Why?
|
Tai Ji | 1 | 2017 | 285 | 0.120 |
Why?
|
Education, Medical, Graduate | 3 | 2021 | 2291 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1405 | 0.110 |
Why?
|
Delirium | 2 | 2022 | 1609 | 0.110 |
Why?
|
Glycerylphosphorylcholine | 1 | 2013 | 25 | 0.110 |
Why?
|
Glutamic Acid | 1 | 2019 | 1169 | 0.110 |
Why?
|
Internship and Residency | 3 | 2021 | 5788 | 0.110 |
Why?
|
Telemedicine | 2 | 2020 | 2872 | 0.110 |
Why?
|
Alcoholism | 1 | 2023 | 1906 | 0.110 |
Why?
|
Research Design | 2 | 2019 | 5987 | 0.110 |
Why?
|
Phosphatidylethanolamines | 1 | 2013 | 134 | 0.110 |
Why?
|
Ethanolamines | 1 | 2013 | 158 | 0.110 |
Why?
|
Behavioral Symptoms | 2 | 2020 | 175 | 0.110 |
Why?
|
Phosphorylcholine | 1 | 2013 | 162 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.100 |
Why?
|
Demography | 3 | 2023 | 1656 | 0.100 |
Why?
|
Education, Medical, Undergraduate | 1 | 2021 | 1008 | 0.100 |
Why?
|
Mitochondria | 3 | 2021 | 3520 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2021 | 1061 | 0.100 |
Why?
|
Retrospective Studies | 10 | 2023 | 77449 | 0.100 |
Why?
|
Preventive Medicine | 1 | 2013 | 264 | 0.100 |
Why?
|
Psychometrics | 2 | 2019 | 3002 | 0.100 |
Why?
|
Policy Making | 1 | 2015 | 554 | 0.100 |
Why?
|
Sex Characteristics | 2 | 2023 | 2585 | 0.100 |
Why?
|
Consensus | 1 | 2020 | 2959 | 0.100 |
Why?
|
Anxiety | 3 | 2020 | 4297 | 0.100 |
Why?
|
Young Adult | 8 | 2021 | 56430 | 0.100 |
Why?
|
Anxiety Disorders | 2 | 2019 | 2690 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2023 | 7279 | 0.090 |
Why?
|
Geriatrics | 1 | 2015 | 396 | 0.090 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 737 | 0.090 |
Why?
|
Drug Resistance | 1 | 2016 | 1609 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.090 |
Why?
|
Data Collection | 3 | 2023 | 3341 | 0.090 |
Why?
|
Psychotherapy, Group | 1 | 1993 | 406 | 0.090 |
Why?
|
Double-Blind Method | 6 | 2021 | 12026 | 0.090 |
Why?
|
Independent Living | 1 | 2014 | 568 | 0.090 |
Why?
|
Chronic Disease | 3 | 2019 | 9146 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15540 | 0.090 |
Why?
|
Specialization | 1 | 2014 | 777 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3022 | 0.080 |
Why?
|
Social Participation | 2 | 2021 | 173 | 0.080 |
Why?
|
Linear Models | 2 | 2010 | 5952 | 0.080 |
Why?
|
Frontal Lobe | 2 | 2021 | 1406 | 0.080 |
Why?
|
Schizophrenia | 4 | 2018 | 6882 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1432 | 0.080 |
Why?
|
Medicine | 1 | 2017 | 946 | 0.080 |
Why?
|
Seizures | 1 | 2020 | 2859 | 0.080 |
Why?
|
Self Report | 1 | 2019 | 3558 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4215 | 0.080 |
Why?
|
Social Adjustment | 1 | 2010 | 631 | 0.080 |
Why?
|
United States | 9 | 2023 | 69872 | 0.080 |
Why?
|
Adaptation, Psychological | 2 | 2020 | 2576 | 0.080 |
Why?
|
Societies, Medical | 1 | 2019 | 3743 | 0.080 |
Why?
|
Adolescent | 7 | 2021 | 85781 | 0.070 |
Why?
|
Freedom | 1 | 2007 | 69 | 0.070 |
Why?
|
Residential Facilities | 1 | 2007 | 43 | 0.070 |
Why?
|
Amyloid beta-Peptides | 1 | 2020 | 3587 | 0.070 |
Why?
|
Age of Onset | 2 | 2015 | 3271 | 0.070 |
Why?
|
Mentors | 2 | 2023 | 631 | 0.070 |
Why?
|
Radiotherapy | 1 | 1993 | 1533 | 0.070 |
Why?
|
Massachusetts | 2 | 2023 | 8663 | 0.070 |
Why?
|
Anorexia | 3 | 2013 | 161 | 0.070 |
Why?
|
Central Nervous System Stimulants | 1 | 2015 | 1148 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8642 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2886 | 0.070 |
Why?
|
Brain Mapping | 2 | 2021 | 6669 | 0.070 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 320 | 0.070 |
Why?
|
Life Style | 1 | 2017 | 3835 | 0.070 |
Why?
|
Sex Factors | 6 | 2019 | 10397 | 0.070 |
Why?
|
Forecasting | 1 | 2014 | 2951 | 0.060 |
Why?
|
Gait Disorders, Neurologic | 1 | 2007 | 231 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2009 | 981 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.060 |
Why?
|
Self Efficacy | 2 | 2010 | 616 | 0.060 |
Why?
|
Stress, Psychological | 2 | 1993 | 4245 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2010 | 941 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6459 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 3966 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4931 | 0.060 |
Why?
|
Schizophrenic Psychology | 1 | 2010 | 1678 | 0.050 |
Why?
|
Protons | 1 | 2008 | 1127 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39050 | 0.050 |
Why?
|
Community Mental Health Services | 1 | 2005 | 386 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4266 | 0.050 |
Why?
|
Databases, Factual | 3 | 2024 | 7729 | 0.050 |
Why?
|
Quality of Life | 3 | 2021 | 12804 | 0.050 |
Why?
|
Control Groups | 1 | 2022 | 105 | 0.050 |
Why?
|
Terminal Care | 1 | 2014 | 1694 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5615 | 0.050 |
Why?
|
Proxy | 1 | 2022 | 144 | 0.050 |
Why?
|
Sleep | 1 | 2017 | 4623 | 0.050 |
Why?
|
Nursing Homes | 2 | 2020 | 1036 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 317 | 0.050 |
Why?
|
China | 2 | 2017 | 2248 | 0.050 |
Why?
|
Professional Competence | 1 | 2004 | 447 | 0.050 |
Why?
|
Length of Stay | 1 | 2014 | 6309 | 0.050 |
Why?
|
Comorbidity | 3 | 2023 | 10388 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2005 | 921 | 0.050 |
Why?
|
Smoking | 1 | 2017 | 8987 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 604 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 53288 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2019 | 63 | 0.040 |
Why?
|
Ecosystem | 1 | 2023 | 474 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35421 | 0.040 |
Why?
|
Risk Factors | 2 | 2016 | 72290 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2022 | 1590 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 170 | 0.040 |
Why?
|
Happiness | 1 | 2019 | 170 | 0.040 |
Why?
|
Prevalence | 3 | 2021 | 15226 | 0.040 |
Why?
|
Problem-Based Learning | 1 | 2021 | 361 | 0.040 |
Why?
|
Macau | 1 | 2016 | 1 | 0.040 |
Why?
|
Social Isolation | 1 | 2020 | 365 | 0.040 |
Why?
|
Videotape Recording | 1 | 1998 | 352 | 0.040 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2019 | 322 | 0.040 |
Why?
|
Nausea | 2 | 1993 | 673 | 0.040 |
Why?
|
Pilot Projects | 2 | 2007 | 8324 | 0.040 |
Why?
|
Employment | 1 | 2023 | 1132 | 0.040 |
Why?
|
Vomiting | 2 | 1993 | 636 | 0.040 |
Why?
|
Cohort Studies | 4 | 2022 | 40561 | 0.040 |
Why?
|
Anger | 1 | 2019 | 402 | 0.040 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2020 | 501 | 0.040 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2019 | 419 | 0.030 |
Why?
|
Decision Support Systems, Clinical | 1 | 2005 | 1164 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 847 | 0.030 |
Why?
|
Quality Improvement | 2 | 2021 | 3749 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2022 | 975 | 0.030 |
Why?
|
Standard of Care | 1 | 2019 | 564 | 0.030 |
Why?
|
Genomics | 2 | 2021 | 5720 | 0.030 |
Why?
|
Quality Assurance, Health Care | 1 | 2005 | 2212 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2020 | 687 | 0.030 |
Why?
|
Homes for the Aged | 1 | 2016 | 260 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2022 | 1221 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2278 | 0.030 |
Why?
|
Attitude to Health | 3 | 1998 | 2052 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 827 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Reaction Time | 1 | 2020 | 2097 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2386 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 1049 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2020 | 676 | 0.030 |
Why?
|
Clozapine | 1 | 2016 | 498 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2429 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1420 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2020 | 1041 | 0.030 |
Why?
|
Fatigue | 2 | 1993 | 1531 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19905 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2187 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2018 | 956 | 0.030 |
Why?
|
Qualitative Research | 1 | 2020 | 2682 | 0.030 |
Why?
|
Cholinesterase Inhibitors | 1 | 2013 | 238 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1147 | 0.020 |
Why?
|
Weight Gain | 1 | 2021 | 2292 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2023 | 1797 | 0.020 |
Why?
|
Neoplasms | 2 | 1993 | 21683 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2000 | 1637 | 0.020 |
Why?
|
Certification | 1 | 2014 | 424 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1432 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3086 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 13881 | 0.020 |
Why?
|
Fear | 1 | 2019 | 1440 | 0.020 |
Why?
|
Accidental Falls | 1 | 2018 | 1062 | 0.020 |
Why?
|
Research | 1 | 1999 | 1999 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2077 | 0.020 |
Why?
|
Visual Perception | 1 | 1998 | 1420 | 0.020 |
Why?
|
Universities | 1 | 2015 | 956 | 0.020 |
Why?
|
Clinical Competence | 2 | 2020 | 4687 | 0.020 |
Why?
|
Decision Making | 1 | 2022 | 3887 | 0.020 |
Why?
|
Child | 3 | 2024 | 77709 | 0.020 |
Why?
|
Case Management | 1 | 2010 | 286 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4933 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3064 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3396 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4161 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14722 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9687 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5255 | 0.020 |
Why?
|
Communication | 1 | 2020 | 3749 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13989 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2488 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12951 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2020 | 4371 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
Social Behavior | 1 | 2010 | 1127 | 0.010 |
Why?
|
Time Factors | 2 | 2017 | 40075 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5137 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2010 | 1827 | 0.010 |
Why?
|
New England | 1 | 2005 | 1022 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7785 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.010 |
Why?
|
Cost of Illness | 1 | 2010 | 1859 | 0.010 |
Why?
|
Awareness | 1 | 1985 | 640 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8949 | 0.010 |
Why?
|
New Hampshire | 1 | 2000 | 172 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.010 |
Why?
|
Utilization Review | 1 | 2000 | 392 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8480 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23338 | 0.010 |
Why?
|
Patient Admission | 1 | 2000 | 1380 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2005 | 3843 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168757 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2000 | 2708 | 0.010 |
Why?
|
Health Status | 1 | 1998 | 4034 | 0.000 |
Why?
|